Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Breast Cancer

  Free Subscription

Articles published in Am J Clin Oncol

Retrieve available abstracts of 16 articles:
HTML format

Single Articles

    July 2022
    Sacituzumab Govitecan-hziy in Breast Cancer.
    Am J Clin Oncol. 2022;45:279-285.
    PubMed     Abstract available

    May 2022
  2. GARBUIO DC, Ribeiro VDS, Hamamura AC, Faustino A, et al
    A Chitosan-Coated Chamomile Microparticles Formulation to Prevent Radiodermatitis in Breast: A Double-blinded, Controlled, Randomized, Phase II Clinical Trial.
    Am J Clin Oncol. 2022;45:183-189.
    PubMed     Abstract available

    April 2022
  3. MERY B, Rowinski E, Rivier C, Bouleftour W, et al
    Cardiovascular Diseases Following Breast Cancer: Towards a Case-by-Case Assessment Through a Prediction Risk Score Model in 943 Patients.
    Am J Clin Oncol. 2022;45:155-160.
    PubMed     Abstract available

    March 2022
  4. OLADERU OT, Ma SJ, Miccio JA, Wang K, et al
    Breast and Cervical Cancer Screening Disparities in Transgender People.
    Am J Clin Oncol. 2022;45:116-121.
    PubMed     Abstract available

    January 2022
  5. ARIANI R, Hwang L, Maliglig AM, Ragab O, et al
    Temporality and Patterns of Metastatic Recurrence in Node-Positive Breast Cancer Following Trimodality Therapy: Opportunity for Improved Oligometastases Detection and Salvage Local Therapy.
    Am J Clin Oncol. 2022 Jan 6. pii: 00000421-900000000-98511.
    PubMed     Abstract available

    July 2021
  6. SUSSELL J, Singh Jhuti G, Antao V, Herrera-Restrepo O, et al
    Cost-effectiveness Analysis of Ado-trastuzumab Emtansine (T-DM1) for the Adjuvant Treatment of Patients With Residual Invasive HER2+ Early Breast Cancer in the United States.
    Am J Clin Oncol. 2021;44:340-349.
    PubMed     Abstract available

    June 2021
  7. SPANHEIMER PM, Bashir A, Lorenzen AW, Beck AC, et al
    A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast Cancer.
    Am J Clin Oncol. 2021 Jun 30. pii: 00000421-900000000-98548.
    PubMed     Abstract available

  8. HIRKO KA, Regan MM, Remolano MC, Schlossman J, et al
    Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer.
    Am J Clin Oncol. 2021 Jun 21. pii: 00000421-900000000-98550.
    PubMed     Abstract available

    May 2021
  9. KIM K, Shim SR, Kim SJ
    Diagnostic Values of 8 Different Imaging Modalities for Preoperative Detection of Axillary Lymph Node Metastasis of Breast Cancer: A Bayesian Network Meta-analysis.
    Am J Clin Oncol. 2021 May 12. pii: 00000421-900000000-98566.
    PubMed     Abstract available

  10. MELHEM J, Amarin M, Odeh G, Al-Bustami N, et al
    Intercostobrachial Nerve (ICBN) Preservation Versus Sacrifice in Axillary Dissection: Randomized Controlled Trial.
    Am J Clin Oncol. 2021;44:206-209.
    PubMed     Abstract available

    March 2021
  11. RIZZI SKLA, Haddad CAS, Giron PS, Figueira PVG, et al
    Exercise Protocol With Limited Shoulder Range of Motion for 15 or 30 Days After Conservative Surgery for Breast Cancer With Oncoplastic Technique: A Randomized Clinical Trial.
    Am J Clin Oncol. 2021 Mar 17. pii: 00000421-900000000-98581.
    PubMed     Abstract available

    January 2021
  12. VALERIO MR, Arrivas Bajardi E, Arcara CC, Borsellino N, et al
    Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety.
    Am J Clin Oncol. 2021 Jan 20. pii: 00000421-900000000-98598.
    PubMed     Abstract available

    November 2020
  13. AMIN NP, Kim SM, Lasio G, Zhou J, et al
    Incidental Coronary Artery Calcium on Breast Radiation Therapy Planning Scans Identifies Patients for Cardiac Preventive Therapy.
    Am J Clin Oncol. 2020;43:826-831.
    PubMed     Abstract available

  14. GUTKIN PM, Ganjoo KN, Lohman M, von Eyben R, et al
    Angiosarcoma of the Breast: Management and Outcomes.
    Am J Clin Oncol. 2020;43:820-825.
    PubMed     Abstract available

    October 2020
  15. ZOLCSAK Z, Loirat D, Fourquet A, Kirova YM, et al
    Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer: Single-center Preliminary Results.
    Am J Clin Oncol. 2020 Oct 6. doi: 10.1097/COC.0000000000000769.
    PubMed     Abstract available

    September 2020
  16. MACARI DM, Gbadamosi B, Jaiyesimi I, Gaikazian S, et al
    Medical Cannabis in Cancer Patients: A Survey of a Community Hematology Oncology Population.
    Am J Clin Oncol. 2020;43:636-639.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.